L02.8
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age over 18; Superficial Skin abscess with Need of Operation; Necessity of Hospital stay
Exclusion criteria
Exclusion criteria: Patients with immunodefiency (HIV, Hepatitis, leukemia, steroidtherapy, autoimmuntherapy); patients that are not able or willing to return for the follow up visits; language barrier; no informed consent; hospitalisation in the last 14 days; abscess of the face or fistula
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Pain: VAS; baseline, after 1, 3, (optional 6) and 12 weeks.) Quality of life: EQ-5D and SF-36; baseline, after 1, 3, (optional 6) and 12 weeks.) Health-related Costs: own questionnaire at 1, 3, (optional 6) and 12 weeks with questions on the number and duration of visits to the attending physician and the ambulant care and material consumption. Scar tissue image, body self-image: POSAS and Vancouver Scar Scale at 12 weeks | — |
Primary
| Measure | Time frame |
|---|---|
| reinfection and revision rates; these are recorded as part of the follow-ups after 1, 3, (optional 6) and 12 weeks by clinical examination In addition, patients may be judged except as planned if the patient, the ambulant care or the attending physician reports a problem with the wound. If there is evidence of reinfection with the need of a change of treatment (eg antiseptic therapy, antibiotics, or the like) or the wound needs to be reoperated, the primary endpoint is reached. | — |
Countries
Switzerland
Contacts
Luzerner Kantonsspital;Luzerner Kantonsspital